Will Fosravuconazole – an anti-fungal drug developed by Eisai Pharmaceuticals in Japan – be more effective treatment than Itraconazole in the treatment of fungal mycetoma?
September 26th, 2019“….Fungal mycetoma – dubbed a “silent killer” – is an infection that burrows into the limbs of its victims, causing massive swelling and peppering patients with lesions and sores. It can lead to disability, limb amputation or – in extreme cases – death.
The current treatment regime is brutal and long – patients take four tablets a day for up to three years but side effects include vomiting and even liver failure. …..”
Countries shown in dark green indicate those in which cases of mycetoma have been reported in the medical literature. The mycetoma belt region is shaded in light green.
Source: WHO